Cargando…

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry

BACKGROUND: Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real‐world patients with acute coronary syndromes treated with percutaneous coronary intervention (PCI) remain unclear. We sought to examine whether treatment with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Völz, Sebastian, Petursson, Petur, Odenstedt, Jacob, Ioanes, Dan, Haraldsson, Inger, Angerås, Oskar, Dworeck, Christian, Hirlekar, Geir, Myredal, Anna, Albertsson, Per, Råmunddal, Truls, Redfors, Björn, Omerovic, Elmir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660716/ https://www.ncbi.nlm.nih.gov/pubmed/32662350 http://dx.doi.org/10.1161/JAHA.119.015990

Ejemplares similares

Radial artery access is associated with lower mortality in patients undergoing primary PCI: a report from the SWEDEHEART registry
por: Dworeck, Christian, et al.
Publicado: (2020)

Characteristics, survival and neurological outcome in out-of-hospital cardiac arrest: A nationwide study of 56,203 cases with emphasis on cardiovascular comorbidities
por: Rawshani, Araz, et al.
Publicado: (2022)

Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes
por: Dworeck, Christian, et al.
Publicado: (2020)

Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
por: Völz, Sebastian, et al.
Publicado: (2021)

Characteristics, survival and neurological outcome in out-of-hospital cardiac arrest in young adults in Sweden: A nationwide study
por: Gustafsson, Linnea, et al.
Publicado: (2023)

PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve
por: Haraldsson, Inger, et al.
Publicado: (2019)

Impact of Thrombus Aspiration on Mortality, Stent Thrombosis, and Stroke in Patients With ST‐Segment–Elevation Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry
por: Angerås, Oskar, et al.
Publicado: (2018)

Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)
por: Redfors, Björn, et al.
Publicado: (2015)

Chronic Total Occlusions in Sweden – A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
por: Råmunddal, Truls, et al.
Publicado: (2014)

Temporal trends in characteristics and outcome of heart failure patients with and without significant coronary artery disease
por: Bollano, Entela, et al.
Publicado: (2022)

No obesity paradox in out-of-hospital cardiac arrest: Data from the Swedish registry of cardiopulmonary resuscitation
por: Hjalmarsson, Alfred, et al.
Publicado: (2023)

Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome?
por: Redfors, Björn, et al.
Publicado: (2014)

Prognostic significance of BMI after PCI treatment in ST-elevation myocardial infarction: a cohort study from the Swedish Coronary Angiography and Angioplasty Registry
por: Jamaly, Shabbar, et al.
Publicado: (2021)

Left-sided valvular heart disease and survival in out-of-hospital cardiac arrest: a nationwide registry-based study
por: Dejby, Ellen, et al.
Publicado: (2023)

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry
por: Persson, Jonas, et al.
Publicado: (2023)

Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome
por: Chen, Yunxian, et al.
Publicado: (2022)

Short‐ and Long‐Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry
por: Redfors, Björn, et al.
Publicado: (2021)

Successful percutaneous coronary intervention during cardiac arrest with use of an automated chest compression device: a case report
por: Libungan, Berglind, et al.
Publicado: (2014)

Coronary angioplasty in octogenarians with emergent coronary syndromes: study protocol for a randomized controlled trial
por: Libungan, Berglind, et al.
Publicado: (2014)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Efficacy and Safety Profile of Ticagrelor Versus Clopidogrel in Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome (ACS): A Systematic Review and Meta-Analysis
por: Maqbool, Shahzaib, et al.
Publicado: (2023)

The effect of ticagrelor on coronary microvascular function after PCI in patients with ACS compared to clopidogrel: A systematic review and meta-analysis
por: Qiu, Xiaohan, et al.
Publicado: (2023)

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
por: Omerovic, Elmir, et al.
Publicado: (2010)

ECG differences and ECG predictors in patients presenting with ST segment elevation due to myocardial infarction versus takotsubo syndrome
por: Zeijlon, Rickard, et al.
Publicado: (2022)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Native cardiac reserve predicts survival in acute post infarction heart failure in mice
por: Täng, Margareta Scharin, et al.
Publicado: (2007)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Moon, Hyeyeon, et al.
Publicado: (2021)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Genetic Polymorphism of CYP2C19 and Inhibitory Effects of Ticagrelor and Clopidogrel Towards Post-Percutaneous Coronary Intervention (PCI) Platelet Aggregation in Patients with Acute Coronary Syndromes
por: Dong, Peng, et al.
Publicado: (2016)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
por: Grima, Daniel T, et al.
Publicado: (2014)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
por: Vlachopoulos, Charalambos, et al.
Publicado: (2019)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
por: Choi, Woong Gil, et al.
Publicado: (2021)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2023)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5cmrk4ucd362c8simv3qe4vlr